battle of glp-1 delivery technologies drugs are already famous for weight loss, but the 2025 OHSU-led trial pushed the story further. Adults with type 1 diabetes using automated insulin and weekly semaglutide were far more Disruptive Innovations Shaping the GLP-1

Metformin followed a similar arc (diabetes drug, then the TAME trial for aging)

The neonatal Fc receptor: Key to homeostasiccontrol of IgG and IgG-related biopharmaceuticals

However, if the swollen area grows larger than 2 inches in diameter or doesnt improve after two days, its time to reach out to your doctor

Kidney transplant recipients exhibit characteristic dysbiosis patterns paralleling those in T2DM, including depletion of SCFA-producing taxa (e.g., Roseburia , Faecalibacterium ) and reduced Akkermansia muciniphila abundance ( The following molecular mechanisms are implicated: SCFA (butyrate) depletioncompromised intestinal tight junction integrity endotoxemia (LPS translocation)TLR4/NF-B-driven systemic metabolic inflammation and insulin resistance

Others find mid-week works better for their routine